Concepedia

Lars Popper

LP

Statistics

Publications

6

Citations

339

H-Index

6

Active since

2008

Affiliations

Norwegian University of Science and Technology(Current)

Takeda (Denmark)

University of Copenhagen

University of South Australia

The University of Adelaide

Lars Popper is an author at Norwegian University of Science and Technology specializing in intranasal fentanyl, pharmacology, and pharmacokinetics.

ORCID

Publications per year

2008–2015

6

Publications

6

Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study

Lona Louring Christrup, David Foster, Lars Popper et al. · Clinical Therapeutics · 2008 · 119 citations

, , +13

Pharmacokinetics and Pharmacodynamics of Intranasal Versus Intravenous Fentanyl in Patients with Pain after Oral Surgery

David Foster, Richard N. Upton, Lona Louring Christrup et al. · Annals of Pharmacotherapy · 2008 · 101 citations

, , +17

Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain

Stein Kaasa, Kristin Moksnes, Thomas Nolte et al. · Journal of Opioid Management · 2011 · 59 citations

, , +17

Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects

Ruediger Nave, H. Schmitt, Lars Popper · Drug Delivery · 2013 · 30 citations

, , +16

Efficacy and Tolerability of Intranasal Fentanyl Spray in Cancer Patients With Breakthrough Pain

Morten Thronæs, Lars Popper, Martin Eeg et al. · Clinical Therapeutics · 2015 · 17 citations

, , +15

1–5 of 6